iBio公开募股定价5000万美元

2025-08-19 20:21

iBio (NASDAQ:IBIO) announced a $50M underwritten public offering.
The offering includes 71.54M pre-funded warrants and Series G and H warrants to purchase a total of 71.54M shares.
Each unit (1 pre-funded warrant + 1 Series G warrant + 1 Series H warrant) is priced at $0.699. Series G and H warrants have an exercise price of $0.70 per share and various expiration terms tied to trial milestones.
The offering is expected to close on or around August 22, 2025.
Proceeds will fund development of cardiometabolic candidates IBIO-610 and IBIO-600, other preclinical assets, and general corporate purposes.
Additional $50M could be raised if all Series G and H warrants are exercised in cash.
IBIO shares down 3% premarket on Tuesday.
Source: Press release

More on iBio